drugset / Trial / NCT02492477
TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients
Non-randomizedParallel-groupOpen-labelHealth-services research
Summary
The benefits and risks of flushing or not flushing the non-used PORT-A-CATH® in cancer patients and the time interval of eventual PORT-A-CATH® flushing are currently unknown. The manufacturers of PORT-A-CATH® recommend regular flushings every 4 weeks. In clinical practice, the intervals are usually at least three months. Regular flushing might lead to a decreased risk of PORT-A-CATH® thrombosis, but may also lead to an increased infection or thrombosis rate and patients discomfort. Therefore, this study investigates the safety of not flushing the PORT-A-CATH® for 6 or 12 months.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Alteplase | Protein / enzyme biologic | — | — |
| Background | Medunasal®-Heparinblock | Unknown | — | — |